This announcement follows closely on another pioneering first for MedReleaf, becoming the first and only LP to receive Health Canada approval to sell cannabis capsules, a format that is favoured by physicians and patients alike as it allows for more consistent dosing.

Everything we do is driven by an unwavering commitment to our patients, the desire to lead Canada’s medical cannabis industry and to strengthen our position as the country’s premium licensed producer. Being Canada’s premium LP means every part of the patient experience should be premium and health focused.

Neil Closner, CEO of MedReleaf

We offer our patients a consistent supply of superior products, the most well-trained patient support team in the country, the safest packaging and now the most convenient, fastest delivery options.

“Same-day delivery is also an important contribution to public health and safety in the GTA,” noted Closner. “Same-day delivery is even more convenient than going to dispensaries or other unregulated channels.”

About MedReleaf’s same-day delivery

MedReleaf’s patients who order – either by phone or online – before 1pm will receive their medication the same day.

There are no restrictions on order size for the same-day option and it applies to dried flower, oils and our industry-exclusive capsules.

Same-day delivery is being offered for a $15 flat fee.

Same-day delivery service is offered to residents of Mississauga, Toronto, Richmond Hill, Vaughan, Brampton and Markham.

About MedReleaf

MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.

For more information on MedReleaf, its products, research and how the company is helping patients #livefree, please visit MedReleaf.com or follow @medreleafcanada

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.